Welch Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,453
| Closed | -$227K | – | 274 |
|
|
2024
Q2 | $227K | Hold |
2,453
| – | – | 0.01% | 228 |
|
|
2024
Q1 | $234K | Buy |
+2,453
| New | +$234K | 0.01% | 200 |
|
|
2023
Q3 | – | Sell |
-2,453
| Closed | -$231K | – | 217 |
|
|
2023
Q2 | $231K | Hold |
2,453
| – | – | 0.01% | 186 |
|
|
2023
Q1 | $203K | Buy |
+2,453
| New | +$203K | 0.01% | 202 |
|
|
2022
Q4 | – | Sell |
-2,453
| Closed | -$203K | – | 221 |
|
|
2022
Q3 | $203K | Hold |
2,453
| – | – | 0.01% | 168 |
|
|
2022
Q2 | $233K | Hold |
2,453
| – | – | 0.01% | 177 |
|
|
2022
Q1 | $289K | Sell |
2,453
-15
| -0.6% | -$1.77K | 0.02% | 168 |
|
|
2021
Q4 | $320K | Buy |
2,468
+15
| +0.6% | +$1.95K | 0.02% | 163 |
|
|
2021
Q3 | $278K | Buy |
2,453
+493
| +25% | +$55.9K | 0.02% | 153 |
|
|
2021
Q2 | $203K | Buy |
+1,960
| New | +$203K | 0.01% | 184 |
|